Hyrimoz® (adalimumab-adaz)
for Psoriasis

Hyrimoz (adalimumab-adaz) is a biosimilar medication used to treat Crohn's disease in adults and children aged 6 or older. It is also prescribed for other conditions in adults, including uveitis, ulcerative colitis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, and hidradenitis suppurativa. The drug works by blocking tumor necrosis factor (TNF), a chemical in the body involved in inflammation and immune responses.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Psoriasis